arrow
L

Liliana Chemello

University of Padua
H指数:39
被引数:5,028

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

In-Hospital Screening Campaign Against Hepatitis C Could Be Effective for Identifying More Patients Who Still Need Treatment
2024-12-100
PRE
Reduction of the Risk of Hepatocellular Carcinoma over Time Using Direct-Acting Antivirals: A Propensity Score Analysis of a Real-Life Cohort (PITER HCV)
2024-04-263
OAAI
Predicting de-novo portal vein thrombosis after HCV eradication: A long-term competing risk analysis in the ongoing PITER cohort

预测HCV根除后新生门静脉血栓形成: 正在进行的PITER队列中的长期竞争风险分析

2023-11-304
OAAI
Profiling the risk of hepatocellular carcinoma after long-term HCV eradication in patients with liver cirrhosis in the PITER cohort
2023-07-0111
OAAI
A prospective study of direct-acting antiviral effectiveness and relapse risk in HCV cryoglobulinemic vasculitis by the Italian PITER cohort

意大利PITER队列对HCV冷球蛋白血症血管炎的直接作用抗病毒有效性和复发风险的前瞻性研究

2022-01-1914
OAAI
Advanced liver disease outcomes after hepatitis C eradication by human immunodeficiency virus infection in PITER cohort
2020-04-119
OAAI
The weight of pre-existing cofactors for liver disease progression in patients who successfully eradicated HCV virus infection: An interim analysis in the PITER cohort
2020-02-010
PREAI
Efficacy and safety of elbasvir/grazoprevir in a large real-life cohort of HCV-infected patients
2019-04-011
PREAI
Treatment of 320 genotype 3 cirrhotic patients with 12 weeks of sofosbuvir/velpatasvir with or without ribavirin: Real life experience from Italy
2019-04-011
PREAI
Efficacy and safety of Elbasvir/Grazoprevir in a large real-life cohort of HCV-infected patients
2019-02-010
PREAI
Treatment of 320 genotype 3 cirrhotic patients with 12 weeks Sofosbuvir/Velpatasvir with or without ribavirin: real life experience from Italy
2019-02-010
PREAI
Liver Angiopoietin-2 Is a Key Predictor of De Novo or Recurrent Hepatocellular Cancer After Hepatitis C Virus Direct-Acting Antivirals
2018-09-15104
OAAI
Newly diagnosed hepatocellular carcinoma in patients with advanced hepatitis C treated with DAAs: A prospective population study

接受DAAs治疗的晚期丙型肝炎患者新诊断的肝细胞癌: 一项前瞻性人群研究

2018-08-01127
PREAI